Infinity Pharma (INFI) Posts Q3 Loss of 36c, Beats Eatimates by 8c
More News related to INFI
- Infinity's IPI-504 Named One of Windhover and Campbell Alliance's "Top 10 Projects to Watch" in Oncology
- Adelene Q. Perkins Named "Best Executive" at Annual Stevie(R) Awards Ceremony
- Infinity to Present at Upcoming Conferences
- Infinity Pharma (INFI) Posts Q3 Loss of 36c, Beats Eatimates by 8c
- Infinity Reports Recent R&D Highlights and Third Quarter 2009 Results
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reports Q3 loss of $0.36, 8 cents better than the analyst estimate of ($0.44). Revenue for the quarter was $13.8 million, which compares to the estimate of $12.41 million.
Related Categories
EarningsStocks Mentioned
-0.30Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
